Insider Trading History of Parekh Rajesh B

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Parekh Rajesh B since 2008. This trader's CIK number is 1429930. At the time of last reporting, Parekh Rajesh B was the Officer of Eloxx Pharmaceuticals, Inc.. (stock ticker symbol ELOX). Also see all insider trading activities at Eloxx Pharmaceuticals, Inc..

Note that in the past PAREKH RAJESH B also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eloxx Pharmaceuticals, Inc. (ELOX) by Parekh Rajesh B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ELOX 2,466,666 $3,329,999 0 $0 0 $0

Yearly summary of insider trading at Celldex Therapeutics, Inc. (CLDX) by Parekh Rajesh B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 CLDX 40,000 $149,360 0 $0 0 $0
2008 CLDX 0 $0 56,223 $630,243 0 $0


Insider trading activities at 2 companies by Parekh Rajesh B:

1. Eloxx Pharmaceuticals, Inc. (ELOX)

2. Celldex Therapeutics, Inc. (CLDX)

Table 1. Insider trading of Eloxx Pharmaceuticals, Inc. (ELOX) by Parekh Rajesh B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-05-13 ELOX Buy 2,466,666 1.35 3,329,999

Table 2. Insider trading of Celldex Therapeutics, Inc. (CLDX) by Parekh Rajesh B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-09-13 CLDX Buy 40,000 3.73 149,360
2008-09-10 AVAN Sale 2,178 10.99 23,947
2008-09-09 AVAN Sale 25,770 11.05 284,810
2008-09-08 AVAN Sale 28,275 11.37 321,486

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Parekh Rajesh B (Officer of Eloxx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.